Peroxovanadate induces tyrosine phosphorylation of multiple signaling proteins in mouse liver and kidney

Abstract

The intraperitoneal injection of a vanadate/H2O2 mixture (peroxovanadate) into mice resulted within minutes in the appearance of numerous tyrosine-phosphorylated proteins in the liver and kidney. These effects are presumably due to the inhibition of phosphotyrosine phosphatase activity. Three of the tyrosine-phosphorylated proteins have been identified as the receptors for epidermal growth factor, insulin, and hepatocyte growth factor. The injection of peroxovanadate also enhanced the tyrosine phosphorylation of many of the proteins known to function downstream of these receptors, including SHC, signal transducer and activator of transcription (Stat) 1α,β, Stat 3, Stat 5, phospholipase C-γ, insulin receptor substrate 1, GTPase-activating protein, β-catenin, γ-catenin, p120(cas), SHP-1, and SHP-2. The administration of peroxovanadate also induced nuclear translocation of a number of tyrosine-phosphorylated Stat proteins. In addition, the global effects on tyrosine phosphorylation permitted the detection of a number of novel intracellular protein interactions, including an association of Tyk2 with β-catenin. The in situ administration of peroxovanadate may prove useful in the search for novel tyrosine- phosphorylated proteins and the identification of new interactions between previously identified tyrosine-phosphorylated substrates.